Return On Equity of Xenetic Biosciences, Inc. from 31 Aug 2012 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Xenetic Biosciences, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Aug 2012 to 30 Sep 2025.
  • Xenetic Biosciences, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -65%, a 31% decline year-over-year.
  • Xenetic Biosciences, Inc. annual Return On Equity for 2024 was -54%, a 49% decline from 2023.
  • Xenetic Biosciences, Inc. annual Return On Equity for 2023 was -36%, a 16% increase from 2022.
  • Xenetic Biosciences, Inc. annual Return On Equity for 2022 was -43%, a 14% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Xenetic Biosciences, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -65% -15% -31% 01 Jul 2025 30 Sep 2025
Q2 2025 -55% -3.5% -6.9% 01 Apr 2025 30 Jun 2025
Q1 2025 -57% -14% -32% 01 Jan 2025 31 Mar 2025
Q4 2024 -54% -18% -49% 01 Oct 2024 31 Dec 2024
Q3 2024 -49% -13% -37% 01 Jul 2024 30 Sep 2024
Q2 2024 -51% -19% -61% 01 Apr 2024 30 Jun 2024
Q1 2024 -43% -2% -4.9% 01 Jan 2024 31 Mar 2024
Q4 2023 -36% +7.1% +16% 01 Oct 2023 31 Dec 2023
Q3 2023 -36% +6.4% +15% 01 Jul 2023 30 Sep 2023
Q2 2023 -32% +11% +25% 01 Apr 2023 30 Jun 2023
Q1 2023 -41% -5.4% -15% 01 Jan 2023 31 Mar 2023
Q4 2022 -43% -5.5% -14% 01 Oct 2022 31 Dec 2022
Q3 2022 -43% -5% -13% 01 Jul 2022 30 Sep 2022
Q2 2022 -42% +67% +61% 01 Apr 2022 30 Jun 2022
Q1 2022 -36% +59% +62% 01 Jan 2022 31 Mar 2022
Q4 2021 -38% +46% +55% 01 Oct 2021 31 Dec 2021
Q3 2021 -38% +39% +51% 01 Jul 2021 30 Sep 2021
Q2 2021 -109% -37% -50% 01 Apr 2021 30 Jun 2021
Q1 2021 -95% -14% -17% 01 Jan 2021 31 Mar 2021
Q4 2020 -84% +4.7% +5.3% 01 Oct 2020 31 Dec 2020
Q3 2020 -77% +29% +28% 01 Jul 2020 30 Sep 2020
Q2 2020 -73% -16% -28% 01 Apr 2020 30 Jun 2020
Q1 2020 -81% -22% -36% 01 Jan 2020 31 Mar 2020
Q4 2019 -89% -27% -43% 01 Oct 2019 31 Dec 2019
Q3 2019 -106% -96% -1015% 01 Jul 2019 30 Sep 2019
Q2 2019 -57% -44% -326% 01 Apr 2019 30 Jun 2019
Q1 2019 -60% -39% -183% 01 Jan 2019 31 Mar 2019
Q4 2018 -62% -33% -113% 01 Oct 2018 31 Dec 2018
Q3 2018 -9.5% +56% +86% 01 Jul 2018 30 Sep 2018
Q2 2018 -13% +59% +82% 01 Apr 2018 30 Jun 2018
Q1 2018 -21% +483% +96% 01 Jan 2018 31 Mar 2018
Q4 2017 -29% +616% +95% 01 Oct 2017 31 Dec 2017
Q3 2017 -66% +890% +93% 01 Jul 2017 30 Sep 2017
Q2 2017 -73% +964% +93% 01 Apr 2017 30 Jun 2017
Q1 2017 -504% -274% -119% 01 Jan 2017 31 Mar 2017
Q4 2016 -645% -459% -246% 01 Oct 2016 31 Dec 2016
Q3 2016 -956% -784% -457% 01 Jul 2016 30 Sep 2016
Q2 2016 -1037% -925% -828% 01 Apr 2016 30 Jun 2016
Q1 2016 -230% -129% -128% 01 Jan 2016 31 Mar 2016
Q4 2015 -186% -94% -101% 01 Oct 2015 31 Dec 2015
Q3 2015 -172% -109% -172% 01 Jul 2015 30 Sep 2015
Q2 2015 -112% 01 Apr 2015 30 Jun 2015
Q1 2015 -101% 01 Jan 2015 31 Mar 2015
Q4 2014 -93% 01 Oct 2014 31 Dec 2014
Q3 2014 -63% 01 Jul 2014 30 Sep 2014

Xenetic Biosciences, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -54% -18% -49% 01 Jan 2024 31 Dec 2024
2023 -36% +7.1% +16% 01 Jan 2023 31 Dec 2023
2022 -43% -5.5% -14% 01 Jan 2022 31 Dec 2022
2021 -38% +46% +55% 01 Jan 2021 31 Dec 2021
2020 -84% +4.7% +5.3% 01 Jan 2020 31 Dec 2020
2019 -89% -27% -43% 01 Jan 2019 31 Dec 2019
2018 -62% -33% -113% 01 Jan 2018 31 Dec 2018
2017 -29% +616% +95% 01 Jan 2017 31 Dec 2017
2016 -645% -459% -246% 01 Jan 2016 31 Dec 2016
2015 -186% -94% -101% 01 Jan 2015 31 Dec 2015
2014 -93% +188% +67% 01 Jan 2014 31 Dec 2014
2013 -280% -278% -11391% 01 Jan 2013 31 Dec 2013
2012 -2.4% 01 Sep 2011 31 Aug 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.